• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于壳聚糖的敷料在控制切除伤口出血方面的疗效。

Efficacy of Chitosan-Based Dressing for Control of Bleeding in Excisional Wounds.

作者信息

Stricker-Krongrad Anne-Heloise, Alikhassy Zahra, Matsangos Nicolette, Sebastian Raul, Marti Guy, Lay Frank, Harmon John W

机构信息

Section of Surgical Sciences, Department of Surgery, John Hopkins Bayview Medical Center, John Hopkins University School of Medicine, Baltimore, Md.

Department of Surgery, Johns Hopkins School of Medicine, Baltimore, Md.

出版信息

Eplasty. 2018 Mar 10;18:e14. eCollection 2018.

PMID:29619144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5863420/
Abstract

Excessive bleeding is a complication of wound debridement in patients receiving anticoagulation treatment. Chitosan is a linear, positively charged polysaccharide that has potential as a hemostatic topical dressing. This study examined the hemostatic efficacy of the chitosan based Opticell dressing (Medline Industries, Chicago, Ill) in heparinized rats with excisional wounds mimicking debridement. Three paired 12-mm excisional wounds were created on the dorsum of 600-g Sprague-Dawley rats 2 hours after intraperitoneal injection of heparin 800 IU/kg. Opticell or gauze dressings were applied with 3 seconds of gentle pressure. : The dressings were left in place until cessation of bleeding. Ten minutes was enough time for complete bleeding cessation in both groups. Gauze and Opticell were weighed before and after bleeding cessation, with the difference representing blood loss. Total blood loss was 627 ± 47 mg/10 min with the standard gauze, but 247 ± 47 mg/10 min with Opticell ( = .002 Mann-Whitney). N = 6 wounds per group. Gauze and Opticell dressings were removed and instantly replaced with 3 seconds of gentle pressure every minute until bleeding cessation. The removed dressings were weighed before and after application. There was less bleeding in the Opticell group at minutes 1, 2, and 3. Gauze: 183 ± 40, 140 ± 30, and 109 ± 15 mg/min vs Opticell: 91 ± 17, 54 ± 8, and 57 ± 11 mg/min). Analysis of variance, Tukey's test, < .05. N = 12 wounds per group. Topical application of Opticell dressing with chitosan has hemostatic effects that could be a useful tool to control bleeding associated with wound debridement.

摘要

出血过多是接受抗凝治疗患者伤口清创的一种并发症。壳聚糖是一种线性带正电荷的多糖,有潜力作为一种止血局部敷料。本研究在模拟清创的切除伤口的肝素化大鼠中检验了基于壳聚糖的Opticell敷料(Medline Industries,芝加哥,伊利诺伊州)的止血效果。在600克的Sprague-Dawley大鼠腹腔注射800 IU/kg肝素2小时后,在其背部制造三个成对的12毫米切除伤口。Opticell或纱布敷料在轻柔按压3秒后应用。敷料保留在位直至出血停止。两组中10分钟的时间足以使出血完全停止。出血停止前后对纱布和Opticell进行称重,差值代表失血量。使用标准纱布时总失血量为627±47毫克/1十分钟,但使用Opticell时为247±47毫克/1十分钟(曼-惠特尼检验,P = 0.002)。每组n = 6个伤口。去除纱布和Opticell敷料,每分钟轻柔按压3秒立即更换,直至出血停止。对去除的敷料应用前后进行称重。Opticell组在第1、2和3分钟时出血较少。纱布:183±40、140±30和109±15毫克/分钟,而Opticell为:91±17、54±8和57±克/分钟)。方差分析,Tukey检验,P < 0.05。每组n = 12个伤口。局部应用含壳聚糖的Opticell敷料具有止血作用,可能是控制与伤口清创相关出血的有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbd/5863420/e14bc43de74e/eplasty18e14_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbd/5863420/eb2c0a8917d4/eplasty18e14_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbd/5863420/7a4f8a0a82bc/eplasty18e14_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbd/5863420/46f2d18433b1/eplasty18e14_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbd/5863420/b1c9e32f20ef/eplasty18e14_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbd/5863420/960d16ffdc25/eplasty18e14_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbd/5863420/e14bc43de74e/eplasty18e14_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbd/5863420/eb2c0a8917d4/eplasty18e14_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbd/5863420/7a4f8a0a82bc/eplasty18e14_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbd/5863420/46f2d18433b1/eplasty18e14_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbd/5863420/b1c9e32f20ef/eplasty18e14_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbd/5863420/960d16ffdc25/eplasty18e14_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fbd/5863420/e14bc43de74e/eplasty18e14_fig6.jpg

相似文献

1
Efficacy of Chitosan-Based Dressing for Control of Bleeding in Excisional Wounds.基于壳聚糖的敷料在控制切除伤口出血方面的疗效。
Eplasty. 2018 Mar 10;18:e14. eCollection 2018.
2
Hemostatic efficacy of two advanced dressings in an aortic hemorrhage model in Swine.两种先进敷料在猪主动脉出血模型中的止血效果。
J Trauma. 2005 Jul;59(1):25-34; discussion 34-5. doi: 10.1097/01.ta.0000171458.72037.ee.
3
A novel highly porous silica and chitosan-based hemostatic dressing is superior to HemCon and gauze sponges.一种新型的基于高孔隙率二氧化硅和壳聚糖的止血敷料优于HemCon和纱布海绵。
J Trauma. 2008 Oct;65(4):884-90; discussion 890-2. doi: 10.1097/TA.0b013e318187800b.
4
Prospective randomised controlled trial of nanocrystalline silver dressing versus plain gauze as the initial post-debridement management of military wounds on wound microbiology and healing.纳米晶银敷料与普通纱布用于军事创伤清创后初期处理对伤口微生物学及愈合影响的前瞻性随机对照试验
Injury. 2014 Jul;45(7):1111-6. doi: 10.1016/j.injury.2013.12.005. Epub 2013 Dec 17.
5
Determination of efficacy of novel modified chitosan sponge dressing in a lethal arterial injury model in swine.新型改性壳聚糖海绵敷料在猪致死性动脉损伤模型中的疗效测定。
J Trauma Acute Care Surg. 2012 Apr;72(4):899-907. doi: 10.1097/TA.0b013e318248baa1.
6
The Hemostatic and Wound Healing Effect of Chitosan Following Debridement of Chronic Ulcers.壳聚糖清创后对慢性溃疡的止血和愈合作用。
Wounds. 2021 Oct;33(10):263-270.
7
Efficacy of three topical hemostatic agents applied by medics in a lethal groin injury model.三种由医护人员应用于致死性腹股沟损伤模型的局部止血剂的疗效。
J Surg Res. 2009 Jun 15;154(2):258-61. doi: 10.1016/j.jss.2008.07.040. Epub 2008 Sep 4.
8
Comparison of hemorrhage control agents applied to lethal extremity arterial hemorrhages in swine.用于猪致死性肢体动脉出血的止血剂比较。
J Trauma. 2005 Oct;59(4):865-74; discussion 874-5. doi: 10.1097/01.ta.0000187655.63698.9f.
9
A special report on the chitosan-based hemostatic dressing: experience in current combat operations.关于壳聚糖基止血敷料的特别报告:当前作战行动中的经验
J Trauma. 2006 Mar;60(3):655-8. doi: 10.1097/01.ta.0000199392.91772.44.
10
Beneficial effects of a novel shark-skin collagen dressing for the promotion of seawater immersion wound healing.新型鲨鱼皮胶原蛋白敷料对促进海水浸泡伤愈合的有益作用。
Mil Med Res. 2017 Oct 27;4(1):33. doi: 10.1186/s40779-017-0143-4.

引用本文的文献

1
Control of Haemorrhage in Orthopaedic Trauma.骨科创伤中的出血控制
J Clin Med. 2024 Jul 22;13(14):4260. doi: 10.3390/jcm13144260.
2
Bioarchitectural Design of Bioactive Biopolymers: Structure-Function Paradigm for Diabetic Wound Healing.生物活性生物聚合物的生物架构设计:糖尿病伤口愈合的结构-功能范式
Biomimetics (Basel). 2024 May 4;9(5):275. doi: 10.3390/biomimetics9050275.
3
Maximizing Postoperative Recovery: The Role of Functional Biomaterials as Nasal Packs-A Comprehensive Systematic Review without Meta-Analysis (SWiM).

本文引用的文献

1
Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine.伤口愈合受损:预测、预防和个性化医学中多专业考量的事实与假说
EPMA J. 2017 Mar 3;8(1):23-33. doi: 10.1007/s13167-017-0081-y. eCollection 2017 Mar.
2
The hemostatic efficacy of chitosan-pads in hemodialysis patients with significant bleeding tendency.壳聚糖垫对有明显出血倾向的血液透析患者的止血效果。
J Vasc Access. 2017 May 15;18(3):220-224. doi: 10.5301/jva.5000707. Epub 2017 Apr 28.
3
Feasibility of improving platelet-rich plasma therapy by using chitosan with high platelet activation ability.
优化术后恢复:功能性生物材料作为鼻腔填塞物的作用——一项无Meta分析的全面系统评价(SWiM)
Pharmaceutics. 2023 May 18;15(5):1534. doi: 10.3390/pharmaceutics15051534.
4
Potential benefits of using chitosan and silk fibroin topical hydrogel for managing wound healing and coagulation.使用壳聚糖和丝素蛋白局部水凝胶促进伤口愈合和凝血的潜在益处。
Saudi Pharm J. 2023 Mar;31(3):462-471. doi: 10.1016/j.jsps.2023.01.013. Epub 2023 Feb 1.
5
A Prospective Multicenter Randomized Controlled Trial to Evaluate the Efficacy of Chitosan Hydrogel Paste in Comparison to Commercial Hydroactive Gel as a Wound Bed Preparation.一项前瞻性多中心随机对照试验,旨在评估壳聚糖水凝胶糊剂与商用亲水凝胶相比作为伤口床准备的疗效。
Indian J Plast Surg. 2022 Dec 22;56(1):44-52. doi: 10.1055/s-0042-1759503. eCollection 2023 Feb.
6
Biomedical materials for wound dressing: recent advances and applications.用于伤口敷料的生物医学材料:最新进展与应用
RSC Adv. 2023 Feb 13;13(8):5509-5528. doi: 10.1039/d2ra07673j. eCollection 2023 Feb 6.
7
High-Power Laser Deposition of Chitosan Polymers: Medical and Environmental Applications.壳聚糖聚合物的高功率激光沉积:医学与环境应用
Polymers (Basel). 2022 Apr 10;14(8):1537. doi: 10.3390/polym14081537.
8
Antimicrobial and Biocompatible Polycaprolactone and Copper Oxide Nanoparticle Wound Dressings against Methicillin-Resistant .抗微生物且生物相容的聚己内酯和氧化铜纳米颗粒伤口敷料对抗耐甲氧西林……
Nanomaterials (Basel). 2020 Aug 28;10(9):1692. doi: 10.3390/nano10091692.
9
Effects of Electrospun Fibrous Membranes of PolyCaprolactone and Chitosan/Poly(Ethylene Oxide) on Mouse Acute Skin Lesions.聚己内酯与壳聚糖/聚环氧乙烷的电纺纤维膜对小鼠急性皮肤损伤的影响
Polymers (Basel). 2020 Jul 16;12(7):1580. doi: 10.3390/polym12071580.
10
Efficacy of a chitosan tampon in the loop electrosurgical excision procedure: A prospective randomized controlled study.壳聚糖止血栓在环形电切术(LEEP)中的疗效:一项前瞻性随机对照研究。
Sci Rep. 2020 Apr 7;10(1):6017. doi: 10.1038/s41598-020-62965-1.
使用具有高血小板激活能力的壳聚糖改善富血小板血浆疗法的可行性。
Exp Ther Med. 2017 Mar;13(3):1176-1180. doi: 10.3892/etm.2017.4041. Epub 2017 Jan 13.
4
Potential blood clotting factors and anticoagulants.潜在的凝血因子和抗凝剂。
Biomed Pharmacother. 2016 Dec;84:356-365. doi: 10.1016/j.biopha.2016.09.057. Epub 2016 Sep 23.
5
Cellular mechanisms of skin repair in humans and other mammals.人类和其他哺乳动物皮肤修复的细胞机制。
J Cell Commun Signal. 2016 Jun;10(2):103-20. doi: 10.1007/s12079-016-0330-1. Epub 2016 May 12.
6
Chitosan scaffold enhances growth factor release in wound healing in von Willebrand disease.壳聚糖支架可增强血管性血友病因子疾病伤口愈合中生长因子的释放。
Int J Clin Exp Med. 2015 Sep 15;8(9):15611-20. eCollection 2015.
7
Comparison of hemostatic dressings for superficial wounds using a new spectrophotometric coagulation assay.使用新型分光光度法凝血检测对浅表伤口止血敷料的比较
J Transl Med. 2015 Nov 30;13:375. doi: 10.1186/s12967-015-0740-5.
8
Postinjury fibrinolysis shutdown: Rationale for selective tranexamic acid.伤后纤溶关闭:选择性使用氨甲环酸的理论依据。
J Trauma Acute Care Surg. 2015 Jun;78(6 Suppl 1):S65-9. doi: 10.1097/TA.0000000000000634.
9
Glycoprotein IIb/IIIa and P2Y12 induction by oligochitosan accelerates platelet aggregation.低聚壳聚糖诱导糖蛋白IIb/IIIa和P2Y12可加速血小板聚集。
Biomed Res Int. 2014;2014:653149. doi: 10.1155/2014/653149. Epub 2014 Aug 28.
10
The modulation of platelet adhesion and activation by chitosan through plasma and extracellular matrix proteins.壳聚糖通过血浆和细胞外基质蛋白对血小板黏附和激活的调节。
Biomaterials. 2011 Oct;32(28):6655-62. doi: 10.1016/j.biomaterials.2011.05.062. Epub 2011 Jun 14.